Vilazodone for the Treatment of Posttraumatic Stress Disorder
Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether vilazodone is effective in the treatmen of
Posttraumatic Stress Disorder (PTSD)and co-morbid mild or more depression.
Phase:
Phase 4
Details
Lead Sponsor:
Southern California Institute for Research and Education